Bringing AAPS to You - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Bringing AAPS to You
Pharmaceutical Technology will feature video coverage of AAPS this month.


Pharmaceutical Technology
Volume 32, Issue 11, pp. 14


Patricia Van Arnum
Like many readers of Pharmaceutical Technology, I will be attending the annual meeting and exhibition of the American Association of Pharmaceutical Scientists (AAPS) in Atlanta, on Nov. 16–20. AAPS always provides a great opportunity to hear the leading minds in the pharmaceutical sciences, and PharmTech will be building on that tradition through a new project that we are launching at AAPS.

Michelle Hoffman, editor-in-chief, Maribel Rios, senior editor, and I will interview session speakers and other industry thought leaders live at the PharmTech booth (Number 1331). These interviews will make up our Vidcast program, which will be posted here and delivered in special AAPS editions of ePT, Pharmaceutical Technology's weekly electronic newsletter.

Moheb Nasr, director of FDA's Office of New Drug Quality Assessment, will discuss FDA's quality-by-design (QbD) initiative as it applies to analytical methods. Excipient manufacturers will offer their views on QbD and how to achieve better process understanding.

Experts will also explain the potential of liquid-filled hard capsules, including their use in early clinical studies as a quick-to-market option, and the promise of nanotechnology in drug delivery. Industry leaders will discuss the fundamentals of particles and powders and the characteristics needed to produce a quality solid dosage form. Speakers will also explain how approaches such as hot-melt extrusion, nanocrystals, and spray-dried solid dispersions can overcome poor solubility. And AAPS President Karen Habucky will share her views on education for pharmaceutical scientists and engineers.

So tune in here for the latest from AAPS.

Patricia Van Arnum is a senior editor of Pharmaceutical Technology.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here